Consumers who subscribe to streaming services are the least likely to cancel Prime Video among all major providers, according to Parks Associates’ Streaming Video Tracker, which found that Prime’s so-called “churn rate” is 8% while streaming service Discovery+ is nearly at 43%.
Parks recently updated its Streaming Video Tracker, which now tracks churn data for 89 total services, of which 85 are SVOD services. Its most recent churn data is from its quarterly consumer survey of 8,000 internet households.
Prime’s unique position in the streaming universe (a “value-added” service for subscribers of Amazon Prime) is the reason for the low churn rate, according to Eric Sorensen, Director, Streaming Video Tracker, Parks Associates, who adds that streaming king Netflix is helping lower its churn rate by providing more subscription options and content.
"Churn is part of the standard business model, but companies are working hard to minimize it and keep consumers engaged longer," said Sorensen, "Amazon Prime Video has held the lowest churn rate for the last two years because it is included with Prime; however, Netflix continues to creep closer and reduce churn by adding more tiers of service and syndicated content."
From the article, "Parks: Prime Video Has Lowest Churn Rate" by Tom Butts
Parks reported that 19 percent of U.S. broadband households intend to purchase a flat-panel TV set by the end of 2015. Roughly 40 percent of those households are looking for a 4K TV set, which is appr...
Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...
A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...
Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...
